Publication:
New Insights in Therapy for Food Allergy

dc.contributor.authorMayorga, Cristobalina
dc.contributor.authorPalomares, Francisca
dc.contributor.authorCañas, José A.
dc.contributor.authorPérez-Sánchez, Natalia
dc.contributor.authorNúñez, Rafael
dc.contributor.authorTorres, María José
dc.contributor.authorGómez, Francisca
dc.contributor.authoraffiliation[Mayorga,C; Palomares,F; Cañas,JA; Núñez,R] Allergy Research Group, Instituto de Investigación Biomédica de Málaga (IBIMA),Málaga, Spain. [Mayorga,C; Pérez-Sánchez,N; Torres,MJ; Gomez,F] Allergy Clinical Unit, Hospital Regional Universitario de Málaga, Málaga, Spain. [Torres,MJ] Medicine Department, Universidad de Málaga-UMA, Málaga, Spain.
dc.date.accessioned2024-02-19T15:28:11Z
dc.date.available2024-02-19T15:28:11Z
dc.date.issued2021-05-10
dc.description.abstractFood allergy is an increasing problem worldwide, with strict avoidance being classically the only available reliable treatment. The main objective of this review is to cover the latest information about the tools available for the diagnosis and treatment of food allergies. In recent years, many efforts have been made to better understand the humoral and cellular mechanisms involved in food allergy and to improve the strategies for diagnosis and treatment. This review illustrates IgE-mediated food hypersensitivity and provides a current description of the diagnostic strategies and advances in different treatments. Specific immunotherapy, including different routes of administration and new therapeutic approaches, such as hypoallergens and nanoparticles, are discussed in detail. Other treatments, such as biologics and microbiota, are also described. Therefore, we conclude that although important efforts have been made in improving therapies for food allergies, including innovative approaches mainly focusing on efficacy and safety, there is an urgent need to develop a set of basic and clinical results to help in the diagnosis and treatment of food allergies.
dc.description.sponsorshipThis research was funded by grants from the Institute of Health “Carlos III” (ISCIII) of the Ministry of Economy and Competitiveness: PI17/01318 and PI18/00288. RETICS ARADyAL (RD16/0006/0001) and Sara Borrell (CD20/00085) Program. Andalusian Regional Ministry of Health (PE-0039-2018; RH-0085-2020 and PI-0099-2020), Senior Clinical Researcher Program (B-0005-2019), and Nicolas Monardes Program (RC-0004-2021). Roche Pharma S.A. “Stop Fuga de Cerebros” Program (SFC-0002-2020). Grants were co-funded by the European Regional Development Fund (ERDF). “Una manera de hacer Europa” “Andalucía se mueve con Europa”.
dc.identifier.doi10.3390/foods10051037
dc.identifier.e-issn2304-8158es_ES
dc.identifier.journalFoodses_ES
dc.identifier.otherhttp://hdl.handle.net/10668/3668
dc.identifier.pubmedID34068667es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/18337
dc.language.isoeng
dc.publisherMultidisciplinary Digital Publishing Institute (MDPI)
dc.relation.publisherversionhttps://www.mdpi.com/2304-8158/10/5/1037/htmes
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAttribution 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectFood allergy
dc.subjectSpecific immunotherapy
dc.subjectNon-specific therapy
dc.subjectHypoallergens
dc.subjectNanoparticles
dc.subjectMicrobiota
dc.subjectHipersensibilidad a los alimentos
dc.subjectInmunoterapia
dc.subjectNanopartículas
dc.subjectMicrobiota
dc.subject.meshFood Hypersensitivity
dc.subject.meshImmunoglobulin E
dc.subject.meshNanoparticles
dc.subject.meshMicrobiota
dc.subject.meshBiological Products
dc.titleNew Insights in Therapy for Food Allergy
dc.typereview article
dc.type.hasVersionVoR
dspace.entity.typePublication
relation.isPublisherOfPublication30293a55-0e53-431f-ae8c-14ab01127be9
relation.isPublisherOfPublication.latestForDiscovery30293a55-0e53-431f-ae8c-14ab01127be9

Files